Understand the evidence. Make informed decisions. Transform your health with clinically-proven GLP-1 peptide therapy backed by rigorous scientific research.
Published peer-reviewed studies on GLP-1 efficacy
Average reduction in clinical trials
Across global clinical research programs
Regulatory approval for weight management
GLP-1 (Glucagon-Like Peptide-1) is a naturally occurring hormone that plays a crucial role in regulating appetite, blood sugar, and metabolism.
GLP-1 peptides work by mimicking a hormone your body naturally produces in the gut after eating. They enhance your body's own satiety signals.
By activating GLP-1 receptors in the brain, these peptides reduce hunger signals and increase feelings of fullness, making it easier to eat less naturally.
Beyond weight loss, GLP-1 peptides improve insulin sensitivity, help regulate blood sugar levels, and may provide cardiovascular protection.
"GLP-1 receptor agonists represent a paradigm shift in obesity treatment, addressing the biological drivers of excess weight rather than relying solely on willpower."
— New England Journal of Medicine, 2024
Understanding the science behind these peptides helps you make informed decisions about your weight loss journey.
Single-receptor agonist
Activates GLP-1 Receptors
Binds to receptors in the brain's appetite center (hypothalamus)
Slows Gastric Emptying
Food stays in stomach longer, promoting sustained fullness
Improves Insulin Response
Enhances glucose-dependent insulin secretion
Published clinical studies (68-week treatment period)
Dual-receptor agonist
Dual Receptor Activation
Activates both GIP and GLP-1 receptors for enhanced effect
Enhanced Satiety Signals
Stronger appetite suppression through dual pathways
Improved Fat Metabolism
GIP receptor activation enhances fat tissue metabolism
Published clinical studies (72-week treatment period)
Both peptides are administered via a simple subcutaneous injection once per week. Our clinical team will guide you through the proper self-injection technique during your consultation.
Real data from peer-reviewed clinical trials published in leading medical journals.
Average across treatment groups
Clinically significant threshold
Tirzepatide 15mg group
Peer-reviewed publications
Semaglutide Clinical Studies
Wilding et al., NEJM 2021. n=1,961 participants. 68-week study demonstrating clinically significant weight loss.
View on PubMed →Tirzepatide Clinical Studies
Jastreboff et al., NEJM 2022. n=2,539 participants. 72-week study showing significant weight loss.
View on PubMed →Lab-verified peptides with full medical supervision. No hidden fees, no surprises.
GLP-1 Receptor Agonist
4 weekly doses included
Dual GIP/GLP-1 Agonist
4 weekly doses included
All prices include doctor consultation, medication, supplies, and delivery.
No automatic renewals - you decide when to continue.
Every batch is tested by independent laboratories to verify 99%+ purity. We provide certificates of analysis upon request.
Healthcare professionals review your health history and monitor your progress. Medical guidance every step of the way.
Temperature-controlled storage and shipping ensures peptide integrity from our facility to your door across Nigeria.
Semaglutide is a GLP-1 receptor agonist, while Tirzepatide is a dual GIP/GLP-1 receptor agonist. This means Tirzepatide activates two hormonal pathways instead of one, which clinical studies show leads to greater average weight loss. Tirzepatide may be more effective for some individuals, but both are clinically proven.
Both medications are administered via a simple subcutaneous injection once per week. The injection is typically given in the abdomen, thigh, or upper arm. Our clinical team will provide detailed video guidance and can walk you through the process via WhatsApp during your first dose.
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These are typically mild to moderate and decrease over time as your body adjusts. Starting at a lower dose and gradually increasing helps minimize side effects. Our doctors will guide you through proper dose titration.
Most patients notice reduced appetite within the first 1-2 weeks. Measurable weight loss typically begins within 4-8 weeks. Clinical trials showed progressive weight loss over 68-72 weeks, with most weight loss occurring in the first 6-12 months. Individual results vary based on starting weight, diet, and activity level.
GLP-1 medications have been studied extensively in clinical trials lasting up to 2+ years. They contain clinically proven active ingredients used for long-term weight management. However, like any medication, they should be used under medical supervision. Our doctors will monitor your progress and can adjust treatment as needed.
We source compounded peptides from verified facilities and conduct independent third-party lab testing on every batch. Each shipment includes proper cold-chain packaging with temperature indicators. Certificates of analysis showing purity levels (99%+) are available upon request.
Yes, we deliver to all states in Nigeria. Lagos deliveries typically arrive within 24-48 hours. Other major cities (Abuja, Port Harcourt, Kano, etc.) receive deliveries within 2-3 business days. All shipments use temperature-controlled packaging to ensure medication integrity.
Fill in your details below and our medical team will contact you within 2 hours to discuss if GLP-1 peptide therapy is right for you.
Fill out a quick form and our medical team will contact you within 2 hours to discuss your personalized treatment plan.
Your information is secure and will only be used to contact you about your consultation.